GGrantIndex
← Search

CONTROLLING THROMBOEMBOLISM AFTER POLYTRAUMA WITH AN RNA THERAPY AGAINST EXCESS FIBRINOGEN

$1,993,215FY2024Defense Health AgencyDOD

Versiti Blood Health, Inc., Milwaukee WI

Investigators

View source on USAspending →